Skip to main content
Year archive

Navamedic — 2023 filings

All 51 regulatory filings released by Navamedic (NAVA) in 2023, sourced directly from the official regulator.

51 Filings
2023 Period
2023 filings (51)
Filing Released Lang
Navamedic ASA: Renewed contract signed with Vitaflo International Limited
Regulatory Filings
2023-12-21 English
Financial calendar
Report Publication Announcement
2023-12-15 English
Navamedic ASA: Mandatory notification of trade
Director's Dealing
2023-12-15 English
Navamedic ASA: Mandatory notification of trade
Director's Dealing
2023-12-15 English
Navamedic and Orion Corporation sign non-binding term sheet for Flexilev® in Europe
Capital/Financing Update
2023-12-13 English
Navamedic ASA: Nok et rekordkvartal med over 50 prosent vekst
Earnings Release Q3 2023
2023-11-01 Norwegian
Navamedic ASA: Record high quarter with above 50 percent growth
Investor Presentation
2023-11-01 English
Navamedic ASA: Nok et rekordkvartal med over 50 prosent vekst
Earnings Release Q3 2023
2023-11-01 Norwegian
Navamedic ASA: Record high quarter with above 50 percent growth
Earnings Release Q3 2023
2023-11-01 English
Navamedic ASA: Invitation to 2023 3rd quarter presentation
Report Publication Announcement
2023-10-27 English
Navamedic ASA - Registration of share capital increase
Share Issue/Capital Change
2023-08-30 English
Navamedic ASA - Mandatory notification of trade by primary insider
Share Issue/Capital Change
2023-08-18 English
Navamedic ASA - Mandatory notification of trade by primary insider
Remuneration Information
2023-08-18 English
NAVAMEDIC ASA: Resolution to increase the share capital in connection with exercise of employee options
Share Issue/Capital Change
2023-08-18 English
Navamedic ASA: Significant growth across the business
Interim / Quarterly Report H1 2023
2023-08-11 English
Navamedic ASA: Betydelig vekst på tvers av virksomheten
Investor Presentation
2023-08-11 English
Navamedic ASA: Significant growth across the business
Interim / Quarterly Report H1 2023
2023-08-11 English
Navamedic ASA: Betydelig vekst på tvers av virksomheten
Interim / Quarterly Report H1 2023
2023-08-11 English
Navamedic ASA: Significant growth across the business
Earnings Release H1 2023
2023-08-11 English
Navamedic ASA: Betydelig vekst på tvers av virksomheten
Earnings Release H1 2023
2023-08-11 Norwegian
Navamedic ASA: Invitation to 2023 2nd quarter presentation
Report Publication Announcement
2023-08-07 English
Report of changes in shareholdings, Navamedic ASA
Major Shareholding Notification
2023-06-22 English
Navamedic ASA: Minutes of Annual General Meeting
AGM Information
2023-06-01 Norwegian
Navamedic ASA: Minutes of Annual General Meeting
AGM Information
2023-06-01 English
Updated recommendation by the nomination committee of Navamedic ASA
Board/Management Information
2023-05-31 English
Navamedic to own a total of 96.33 per cent of shares in Sensidose following closing of public offer
Delisting Announcement
2023-05-26 English
Navamedic ASA: Notice of Annual General Meeting
AGM Information
2023-05-11 Norwegian
Navamedic ASA: Notice of Annual General Meeting
AGM Information
2023-05-11 English
Navamedic ASA Q1 2023: Nok et sterkt kvartal
Investor Presentation
2023-05-11 English
Navamedic ASA Q1 2023: Nok et sterkt kvartal
Earnings Release Q1 2023
2023-05-11 Norwegian
Navamedic ASA Q1 2023: Another strong quarter
Investor Presentation
2023-05-11 English
Navamedic ASA Q1 2023: Another strong quarter
Earnings Release Q1 2023
2023-05-11 English
Navamedic increases the consideration to SEK 8.50 in cash per share in its unconditional public offer and convenes an extraordinary general meeting of Sensidose Aktiebolag
M&A Activity
2023-05-10 English
Navamedic increases the consideration to SEK 8.50 in cash per share in its unconditional public offer and convenes an extraordinary general meeting of Sensidose Aktiebolag
M&A Activity
2023-05-10 English
Navamedic ASA: Invitation to 2023 1st quarter presentation
Report Publication Announcement
2023-05-08 English
Navamedic ASA: Annual Report for 2022
Annual Report FY 2022
2023-04-28 English
Navamedic ASA: Annual Report for 2022
Annual Report FY 2022
2023-04-28 English
Navamedic ASA: Annual Report for 2022
Report Publication Announcement
2023-04-28 English
Navamedic ASA: Amended cash offer to acquire Sensidose AB and acquisition of shares in Sensidose AB
M&A Activity
2023-04-22 English
Navamedic ASA: Amended cash offer to acquire Sensidose AB and acquisition of shares in Sensidose AB
M&A Activity
2023-04-22 English
Navamedic ASA: Recommended cash offer to acquire Sensidose for approximately SEK 75 million
M&A Activity
2023-03-29 English
Navamedic ASA: Recommended cash offer to acquire Sensidose for approximately SEK 75 million
M&A Activity
2023-03-29 English
Flagging notification Navamedic ASA
Major Shareholding Notification
2023-03-03 English
NAVAMEDIC ASA: GRANT OF OPTIONS TO PRIMARY INSIDERS
Director's Dealing
2023-02-16 English
NAVAMEDIC ASA: GRANT OF OPTIONS TO PRIMARY INSIDERS
Remuneration Information
2023-02-16 English
Navamedic ASA: Q4 2022 financial results
Investor Presentation Q4 2022
2023-02-16 Norwegian
Navamedic ASA: Q4 2022 financial results
Earnings Release Q4 2022
2023-02-16 English
Navamedic ASA: Resultater for fjerde kvartal 2022
Investor Presentation Q4 2022
2023-02-16 Norwegian
Navamedic ASA: Resultater for fjerde kvartal 2022
Earnings Release Q4 2022
2023-02-16 Norwegian
Navamedic ASA: Invitation to 2022 4th quarter presentation
Report Publication Announcement
2023-02-13 English
Navamedic ASA launches Modifast in Norway
Regulatory Filings
2023-01-30 English